IL1B and synovial sarcoma: Our results showed that patients with SS did not show differences in IL-4 and IL-13 when compared to the other groups of patients, suggesting these cytokines may not inhibit the expression of IL-1α, IL-1β, IL-6 and T lymphocytes may not be completely activated in this group of patients (Figure 8).